Day: October 12, 2026

Proteolysis Targeting Chimeras (PROTACs) have transformed drug discovery by shifting small-molecule therapeutics from an occupancy-driven paradigm (blocking active sites) to an event-driven catalytic mechanism (degrading target proteins). However, translating initial “hitting pairs” into clinical-stage candidates presents unique challenges. Living in...